Kirkland Guides Health-Focused SPAC's $500M IPO Plans

Law360 (September 15, 2020, 6:32 PM EDT) -- A special purpose acquisition company co-founded by a former KKR dealmaker and a biotechnology executive said Tuesday it plans to raise roughly $500 million in an initial public offering steered by Kirkland & Ellis LLP.

California-headquartered Montes Archimedes Acquisition Corp. said it plans to sell 50 million units at $10 apiece, with each unit consisting of one share of common stock and one-half of a redeemable warrant. Each whole warrant will allow the holder to buy one share of common stock for $11.50, the company said in U.S. Securities and Exchange Commission filings.

Montes Archimedes is a special purpose acquisition company,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!